EXPERIENCE TREATING UROGENITAL CANDIDIASIS
- Authors: OLINICHENKO S.A1
-
Affiliations:
- Angara Town Perinatal Center
- Issue: No 7-1 (2011)
- Pages: 68-69
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246624
- ID: 246624
Cite item
Open Access
Access granted
Abstract
Objective. To evaluate the efficacy and safety of livarol in the treatment of urogenital candidiasis in pregnant women. Subjects and methods. Thirty-two pregnant women in their second and third trimesters were followed up. All the patients received livarol, one suppository once daily, for 5 days. They were examined before and 7 days and 1 month after termination of therapy. The vaginal microflora was examined by microscopic and culture techniques. Results. The efficiency of the proposed livarol therapy following 7 days was 90.6 %. A month after termination of livarol therapy, 93.8% of the patients showed a complete clinical resolution: there were neither complaints nor objective clinical and laboratory signs of vaginal candidiasis. Conclusion. Livarol is effective and safe in treating urogenital candidiasis in pregnant women.
Keywords
Full Text
References
- Байрамова Г.Р. Современный взгляд на проблему хронического рецидивирующего вульвовагинального кандидоза // Акуш. и гин. — 2008. — № 4. — С. 52-56.
- Кошелева Н.Г., Плужникова Т.А. Санкт-Петербургский центр профилактики и лечения невынашивания беременности. Итоги научной и практической деятельности // Журн. акуш. и жен. бол. — 2002. — № 2. — С.84-86.
- Прилепская В.Н., Анкирская А.С., Байрамова Г.Р., Муравьева В.В. Вагинальный кандидоз. — М., 1997.
- Ранние сроки беременности // Под ред. В.Е. Радзинского, А.А. Оразмурадова. — М.: Status Praesens, 2009.
- Свердлова Е.С. Заболевания шейки матки: алгоритмы диагностики и технологии лечения. Монография. — Иркутск, 2010.
- Тютюнник В.Л. Вагинальный кандидоз и беременность: этиология, патогенез, клиника, диагностика, лечение // Гинекология. — 2001. — Т. 3, № 3. — С. 89-90.
Supplementary files
